Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Highly expressed B3GALT5-AS1 contributes to gastric cancer progression by recruiting WDR5 to mediate B3GALT5 and regulating β-catenin/ZEB1 axis. | J Cell Mol Med | 2024 | 39224045 | PubTator, text mining | PubMed |
| The Wdr5-H3K4me3 Epigenetic Axis Regulates Pancreatic Tumor Immunogenicity and Immune Suppression. | Int J Mol Sci | 2024 | 39201460 | PubTator, text mining | PubMed |
| Host WD repeat-containing protein 5 inhibits protein kinase R-mediated integrated stress response during measles virus infection. | J Virol | 2024 | 39194235 | PubTator, text mining | PubMed |
| Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies. | Proc Natl Acad Sci U S A | 2024 | 39167600 | PubTator, text mining | PubMed |
| USP36 regulates the proliferation, survival, and differentiation of hFOB1.19 osteoblast. | J Orthop Surg Res | 2024 | 39152465 | PubTator, text mining | PubMed |
| Biomimetic concentric microgrooved titanium surfaces influence bone marrow-derived mesenchymal stem cell osteogenic differentiation via H3K4 trimethylation epigenetic regulation. | Dent Mater J | 2024 | 39135261 | PubTator, text mining | PubMed |
| Blocker-SELEX: a structure-guided strategy for developing inhibitory aptamers disrupting undruggable transcription factor interactions. | Nat Commun | 2024 | 39117705 | PubTator, text mining | PubMed |
| Quantitative Hydrogen-Deuterium Exchange Mass Spectrometry for Simultaneous Structural Characterization and Affinity Indexing of Single Target Drug Candidate Libraries. | Anal Chem | 2024 | 39074309 | PubTator, text mining | PubMed |
| Initial Characterization of WDR5B Reveals a Role in the Proliferation of Retinal Pigment Epithelial Cells. | Cells | 2024 | 39056772 | PubTator, text mining | PubMed |
| Real-Time Measurement of a Weak Interaction of a Transcription Factor Motif with a Protein Hub at Single-Molecule Precision. | ACS Nano | 2024 | 39049818 | PubTator, text mining | PubMed |
| Diagnostic utility of Brain Injury Guidelines (BIG): systematic review and meta-analysis for prediction of neurosurgical intervention in traumatic brain injury. | Brain Inj | 2024 | 39041483 | PubTator, text mining | PubMed |
| Rational design of small-sized peptidomimetic inhibitors disrupting protein-protein interaction. | RSC Med Chem | 2024 | 39026653 | PubTator, text mining | PubMed |
| Epigenetic control of SOX9 gene by the histone acetyltransferase P300 in human Sertoli cells. | Heliyon | 2024 | 39022079 | PubTator, text mining | PubMed |
| Identification of 5-Thiocyanatothiazol-2-amines Disrupting WDR5-MYC Protein-Protein Interactions. | ACS Med Chem Lett | 2024 | 39015274 | PubTator, text mining | PubMed |
| Nuclear miRNAs: Gene Regulation Activities. | Int J Mol Sci | 2024 | 38892257 | PubTator, text mining | PubMed |
| Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode. | J Biol Chem | 2024 | 38876301 | PubTator, text mining | PubMed |
| Molecular insights into regulatory RNAs in the cellular machinery. | Exp Mol Med | 2024 | 38871819 | PubTator, text mining | PubMed |
| Small but mighty: the rise of microprotein biology in neuroscience. | Front Mol Neurosci | 2024 | 38807924 | PubTator, text mining | PubMed |
| PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis. | Cancer Lett | 2024 | 38750719 | PubTator, text mining | PubMed |
| The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif. | Cell Death Dis | 2024 | 38744853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=8